Effect of Ev.FV on Wound Healing in Dystrophic Epidermolysis Bullosa

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Dystrophic Epidermolysis Bullosa · Wound Heal

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Alzahra Hospital, Isfahan, Iran
Contact: Study coordinator (Leila Dehghani, Prof) · l_dehghani2002@yahoo.com · 36202020
Contact: Study coordinator (Masoud Soleimani, Prof) · soleimani.masoud@gmail.com · 36202020

Study leads

Masoud Soleimani, Prof
Study Director
Shahid Beheshti University of Medical Sciences

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Phase 2 Study of TCP-25 Gel in Patients With Epidermolysis Bullosa, STEP-study

Epidermolysis Bullosa (EB) · Dystrophic Epidermolysis Bullosa · Junctional Epidermolysis Bullosa

Abroad (travel likely)RecruitingPHASE2

Paris, France · Athens, Greece

Targeting Collagen VII Antibodies With IV IgG in Dystrophic Epidermolysis Bullosa

Epidermolysis Bullosa · Epidermolysis Bullosa Acquisita · Dystrophic Epidermolysis Bullosa

Abroad (travel likely)RecruitingPHASE1, PHASE2

Redwood City, United States

GMEB-SASS: A Gene-Modified Skin Substitute for RDEB Treatment

RDEB · Recessive Dystrophic Epidermolysis Bullosa · Epidermolysis Bullosa Dystrophica, Recessive

Abroad (travel likely)RecruitingPHASE1, PHASE2

Toronto, Canada

MSC EVs in Dystrophic Epidermolysis Bullosa

Dystrophic Epidermolysis Bullosa

Abroad (travel likely)RecruitingPHASE1, PHASE2

Phoenix, United States · Los Angeles, United States